Observational studyReproductive biology and endocrinology : RB&E2025
Impact of ejaculation frequency on semen parameters and DNA fragmentation: a cross-sectional study.
Observational study in Reproductive biology and endocrinology : RB&E, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06127875 (Effects of Trying to Conceive Using an Home- or Hospital-based Ovulation Monitoring on Stress), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Trying to Conceive Using an Home- or Hospital-based Ovulation Monitoring on Stress
Who cites it
4 citing papers in PubMed.
- Modifiable predictors of patency after microsurgical vasoepididymostomy: associations of adjunctive escin, prior percutaneous epididymal sperm aspiration, and postoperative ejaculatory frequency.World journal of urology · 2026Article
- Integrating Sperm Microscopy, Environmental Exposures, and Lifestyle Factors for Male Fertility Analysis: Protocol for the Nippon Semen and Environmental Exposure Database (N-SEED) Cross-Sectional Study.JMIR research protocols · 2026Article
- Association of sperm DNA fragmentation with abstinence duration, seminal oxidative stress and age: a call to consider abstinence in andrological diagnostics.Frontiers in urology · 2026Article
- Bridging Methodology and Clinical Relevance: Toward More Robust Evidence for Antiox-idant Therapy in Male Infertility.International braz j urol : official journal of the Brazilian Society of UrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAbnormal sperm quality, particularly high sperm DNA fragmentation levels, is associated with infertility and a higher risk of pregnancy loss. While short abstinence periods may improve semen quality, the specific role of ejaculation frequency (EF) remains unclear. EF refers to the number of times an individual ejaculates within a given period, which is distinct from the abstinence period, defined as the time interval between ejaculations. This study investigates the association between EF and semen quality, including sperm DNA fragmentation.
methodsThis cross-sectional study included 1,349 men who underwent semen analysis at a reproductive center between November 2023 and July 2024. The subjects were categorized into three groups based on their self-reported EF over the past four weeks: EF1: <1/week, EF2: ≥1 and <2/week, and EF3: ≥2/week.
resultsAs EF increased, significant decreases were observed in sperm DNA fragmentation index (DFI) (P < 0.001), semen volume (P = 0.012), sperm concentration (P < 0.001), and total sperm count (P < 0.001). Sperm vitality showed a positive association with EF (P < 0.001), while no association was found between sperm progressive motility and EF. Lower risks of elevated sperm DFI and necrozoospermia were observed in EF2 and EF3 compared to EF1. However, there was no increased risk of oligozoospermia or asthenozoospermia with increased EF.
conclusionsHigher ejaculation frequency is associated with improved sperm vitality and lower DFI without negatively impacting motility. EF should be considered alongside abstinence in male fertility assessments.
trial registrationThe study was registered on ClinicalTrials.gov (identifier NCT06127875). DATE OF REGISTRATION: November 11th, 2023. Date of enrollment of the first subject: November 11th, 2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.